Conférencières et conférenciers invités :

  • Sandrine BOURDOULOUS, Institut Cochin, Paris, FR
    New strategies to combat pathogenic bacteria: the example of Neisseria meningitidis
  • Maximiliano GUTIERREZ, Francis Crick Institute, London, UK
    Intracellular environments and antibiotic efficacy in tuberculosis
  • Christophe LACROIX, ETH Zurich, CH
    Novel technologies can accelerate the development of live biotherapeutic products
  • Frédérique LE ROUX, Station Biologique de Roscoff, FR
    Explaining the previously enigmatic bacterial pangenome
  • Laure WEISSKOPF, University of Fribourg, CH
    Plant-associated bacteria and their impact on plant health


Vous pouvez télécharger la version pdf du programme ICI

Programme détaillé

13:00   Accueil

Biotechnologies & Biotherapy (Chair Fayza Daboussi)

13:30 Sophie Lajus TBI-INSA Microfluidics for microbiomics: how to boost enzyme discovery from microbial ecosystems
13:50 Stéphanie Heux TBI-INSA Encapsulation of a synthetic methylotrophic pathway in a bacterial microcompartment
14:10 Kevin Debatisse TBI-INSA Reprogramming the recombination specificity of a phage integrase: a new tool for genome engineering ?
14:30 Aude Ferran InTheRes Combination of bacteriophages and ciprofloxacin to prevent the selection of resistant Pseudomonas aeruginosa
14:50 Catherine Turlan LMGM-CBI The Genetic Engineering Department of LMGM-CBI: a resource center in microbiology and bacterial genetics
15:10 Pause

15:40 Christophe Lacroix  ETH-Zurich  Novel technologies can accelerate the development of live biotherapeutic products
16:20 Anne Boyeldieu LMGM-CBI Deciphering the mode of action of the RumC bacteriocins in Streptococcus pneumoniae
16:40 Bernard Dumas LRSV Identification and characterization of new microbial strains for plant protection and nutrition: The BioPlantProducts project

Environment/One health (Chair Guillaume Charrière)

17:00 Pauline Sorlin Hydro
Achromobacter xylosoxidans, an emerging pathogen with specific pathophysiological traits in cystic fibrosis
17:20 Ginaini Grazielli Doin de Moura LIPME Experimental evolution-driven emergence of legume symbionts: insights into the genetic bases and selective forces
17:40 Frédérique Le Roux Station Biologique
de Roscoff
Explaining the previously enigmatic bacterial pangenome

Microbiology (Chair Matteo Bonazzi)

09:00Hugo LebretteLMGM-CBIMetal utilization in genome-reduced bacteria: Do mycoplasmas rely on iron?
09:20Mattheo AlcarazIRIMEfficacy and mode of action of a direct inhibitor of Mycobacterium abscessus InhA
09:40Célia BernardIPBSAntibiotic tolerance in Mycobacterium abscessus
10:30Isabelle OswaldToxalimFood contaminants exacerbate the effect of bacterial toxins
10:50Alessandra OcchialiniIRIMAntibacterial activity and mechanism of action of Mediterranean fungal extracts against pathogenic Gram+ bacteria
11:10 Sandrine Bourdoulous Institut Cochin New strategies to combat pathogenic bacteria: the example of Neisseria meningitidis

Host-pathogen interactions (Chair Christine Citti)

11:50Stéphane PontLPHIZebrafish embryo infection model to investigate pathogenesis of clinical Pseudomonas aeruginosa isolates and assess the efficiency of therapeutics
12:10Karim MajzoubIGMMHepatitis Delta Virus (HDV) and HDV-like agents in human and animal hosts
12:30Caroline GoujonIRIMIntrinsic and innate immune defenses against RNA viruses
14:20Maryse LebrunLPHIEvolution-based approaches to decipher the mechanism of secretion of virulence factors in apicomplexan parasites
14:40Céline CosseauIHPEEarly life microbial exposures shape the Crassostrea gigas immune system for lifelong and intergenerational disease protection

Host-pathogen interactions (Chair Olivier Neyrolles)

15:00Rémi MascarauIPBSA novel mechanism for productive HIV-1 infection of tissue macrophages
15:20Etienne MeunierIPBSWorld War Z: From unrelated diseases to host immune protection against infections
15:40Nicolas CenacIRSDLipopeptides produced by the microbiota: from hypersensitivity to therapy in visceral pain
16:30Laure DavidIRSDNew mechanisms of action of bacterial outer membrane vesicles contributing to the virulence of pathogenic Escherichia coli
16:50Raphaël BoursereauINFINITyImpact of chronic Toxoplasma gondii infection on cognitive decline and frailty in a mouse model of Alzheimer’s Disease
17:10Chloé DimeglioINFINITyImmune response to SARS-CoV-2: lessons from the SEROCOV study
17:30Maximiliano GutierrezFrancis Crick InstituteIntracellular environments and antibiotic efficacy in tuberculosis

Ecology/Evolution (Chair Claude Bruand)

09:00Xavier NouvelIHAPExploration of pathogenic hemoplasmas in wild and domestic ruminants
09:20Jean-Baptiste FerdyEDBPathogen within-host dynamics: a modeling approach
09:40Caroline BaroukhLIPMEPlant physiology, microbiology and mathematical modeling to assess the growth potential of plant pathogens on xylem sap
 10:00Laure WeisskopfUniversity of Fribourg Plant-associated bacteria and their impact on plant health
11:10Table ronde Présentation des Programmes et équipements prioritaires de recherche (PEPR)
– MIE (Hervé Raoul)
– PREZODE (Christine Citti)
– OneWater (Jean-Raynald de Dreuzy)

Animation : Olivier Neyrolles

12:10Clôture de la conférence